Ravgen Inc. is a privately owned biotech company founded in 2000 by Chairman and C.E.O. Dr. Ravinder Dhallan.[1] Ravgen Inc. performs research in the prenatal diagnostic field and has developed non-invasive prenatal diagnosis testing for Down Syndrome.[2]

Publications and research

edit

Ravgen has published peer-reviewed articles on genetic research in publications such as the Journal of the American Medical Association in 2004,[3] The Lancet in 2007,[4] and the New England Journal of Medicine in 2012.[5] In addition, Ravgen has received some acclaim from its research on non-invasive prenatal DNA testing.[6]

References

edit
  1. ^ Hanoon, Alaa; Rahan, Nur Nadiah Mohd; Hamid, Nur Nadiah Abd; Ismail, Ahmad Izani Md (2018). Solving the nonlinear Camassa Holm equation using quartic trigonometric B-spline collocation method. Mathematical Sciences as the Core of Intellectual Excellence (Sksm25). AIP Conference Proceedings. Vol. 1974. Author(s). p. 020034. Bibcode:2018AIPC.1974b0034H. doi:10.1063/1.5041565.
  2. ^ Humphries, Courtney (February 2, 2007). "A Simpler Test for Detecting Down's Syndrome | MIT Technology Review". Technologyreview.com. Retrieved August 17, 2013.
  3. ^ Dhallan, Ravinder; Au, W. C.; Mattagajasingh, S.; Emche, S.; Bayliss, P.; Damewood, M.; Cronin, M.; Chou, V.; Mohr, M. (2004). "Methods to Increase the Percentage of Free Fetal DNA Recovered from the Maternal Circulation". JAMA. 291 (9). The Journal of the American Medical Association: 1114–1119. doi:10.1001/jama.291.9.1114. PMID 14996781. Archived from the original on May 11, 2012.
  4. ^ Dhallan, Ravinder; Guo, Xin; Emche, Sarah; Damewood, Marian; Bayliss, Philip; Cronin, Michael; Barry, Julie; Betz, Jordan; Franz, Kara; Gold, Katie; Vallecillo, Brett; Varney, John (2007). "A noninvasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study". The Lancet. 369 (9560): 474–481. doi:10.1016/S0140-6736(07)60115-9. PMID 17292767. S2CID 43348652.
  5. ^ Guo, Xin (2012). "A Noninasive Test to Determine Paternity in Pregnancy". The New England Journal of Medicine. 366 (18): 1743–1745. doi:10.1056/NEJMc1113044. PMID 22551147.
  6. ^ "Health | Hope for safe prenatal gene test". BBC News. February 2, 2007. Archived from the original on April 19, 2012. Retrieved August 17, 2013.
edit